Literature DB >> 6018508

Amino acid transport: evidence for genetic control of two types in human kidney.

C R Scriver, O H Wilson.   

Abstract

A mutation affecting renal transport of proline, hydroxyproline, and glycerine occurs in man. In the presumed homozygote there is still significant residual transport of these compounds; however, this remaining function is saturated at normal concentrations of substrate in the plasma and is not inhibited by L-proline in the expected way. The presumed heterozygote has partial loss of a transport system common to the three substrates, which becomes saturated at high concentrations of substrate and is inhibited by L-proline. Two different types of transport systems are proposed: a common system and systems with lower capacity and greater specificity. The two types of transport appear to be controlled by separate genes.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6018508     DOI: 10.1126/science.155.3768.1428

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Iminoglycinuria in a child in Czechoslovakia.

Authors:  B Blehová; N Păzoutová; J Hyánek; J Jirásek
Journal:  Humangenetik       Date:  1973-07-20

2.  Renal tubular transport of proline, hydroxyproline, and glycine. 3. Genetic basis for more than one mode of transport in human kidney.

Authors:  C R Scriver
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

3.  Iminoglycinuria--a "harmless" inborn error of metabolism?

Authors:  G R Fraser; A I Friedmann; V M Patton; D N Wade; L I Woolf
Journal:  Humangenetik       Date:  1968

4.  The prognosis and management of renal tubular disorders.

Authors:  M D Milne
Journal:  Proc R Soc Med       Date:  1967-11-01

5.  Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.

Authors:  Stefan Bröer; Charles G Bailey; Sonja Kowalczuk; Cynthia Ng; Jessica M Vanslambrouck; Helen Rodgers; Christiane Auray-Blais; Juleen A Cavanaugh; Angelika Bröer; John E J Rasko
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.